NORTHERN TRUST CORP - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$3,284,649
+45.3%
687,165
+29.2%
0.00%
Q2 2023$2,260,933
-19.5%
531,984
+0.6%
0.00%
-100.0%
Q1 2023$2,809,018
-16.3%
529,005
-1.0%
0.00%0.0%
Q4 2022$3,356,578
-39.2%
534,487
+2.2%
0.00%0.0%
Q3 2022$5,519,000
+125.8%
523,158
+16.2%
0.00%0.0%
Q2 2022$2,444,000
-34.1%
450,080
+11.5%
0.00%0.0%
Q1 2022$3,706,000
+33.5%
403,770
+119.3%
0.00%
Q4 2021$2,777,000
-32.7%
184,087
+6.4%
0.00%
-100.0%
Q3 2021$4,129,000173,0010.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders